Home » Newsletters » BioWorld Science

BioWorld Science

July 19, 2012

View Archived Issues

First clinical data disclosed on new beta-secretase 1 inhibitor for Alzheimer's disease

Researchers at Boehringer Ingelheim patent new CXCR2 receptor antagonists

Novel protein kinase inhibitors synthesized at Bayer Schering Pharma

Novel data disclosed on Esteve drugs for pain

Epizyme scientists disclose new DOT1-like protein inhibitors

New GlyT1 inhibitors presented

Novel neprilysin inhibitors discovered at Theravance

Taisho Pharmaceutical develops new orexin receptor antagonists

Abbott designs new antiviral agents

Amicus and GSK expand collaboration

Agios Pharmaceuticals patents novel PKM2 activators

Convergence Pharmaceuticals plans phase change for CNV-2197944

Novel product reduces accumulation of oligomeric beta-amyloid in brain

Chugai submits NDA for ibandronate sodium hydrate

Dosing begins in BB3 acute myocardial infarction study

AMAG Pharmaceuticals reports preliminary data from IDA-301 trial

First clinical trials assess TOL-101 for preventing kidney transplant rejection

Novavax and PATH partner to develop RSV vaccine for maternal immunization

Alexza reports on Adasuve MAA

Pluristem engages CPC for phase II trial of PLX-PAD

Sanofi enters collaboration with Brigham and Women's Hospital

Infinity Pharmaceuticals regains rights to PI3K, FAAH and early discovery programs

EMA to review MAA for bazedoxifene/conjugated estrogens

Royal Melbourne Institute of Technology to research use of BioDiem's LAIV for noninfluenza vaccines

Phase III trial of rebamipide ophthalmic suspension begins

New S100-A4-neutralizing antibody is a potential therapy and biomarker for cancer

Aeras and IAVI expand vaccine research partnership

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...